Form 4: Amylyx Pharmaceuticals CFO Sells Shares
Insider Transaction (Form 4)
James M Frates, Chief Financial Officer of Amylyx Pharmaceuticals, Inc., sold 10,810 shares of common stock on September 10, 2026.
Summary
- Open-market sale: disposed of 9,768 Common Stock at $32.27 ($315,195) on September 10, 2026; holds 234,667 after (Direct).
- Open-market sale: disposed of 1,042 Common Stock at $33.23 ($34,626) on September 10, 2026; holds 233,625 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $349,821 of stock on the open market.
Insider Transactions
James M Frates — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Open-market sale | Common Stock | 9,768 | $32 | $315.2K | 234,667 |
| 2026-09-10 | Open-market sale | Common Stock | 1,042 | $33 | $34.6K | 233,625 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Open-market sale (9,768 shares) |
| 2026-09-10 | Open-market sale (1,042 shares) |
Keywords
insider transaction, Form 4, AMLX, Amylyx Pharmaceuticals, Inc., bearish, James M Frates
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.